Rhodes et al v. Rhodes Technologies, Inc. et al
| Anthony Silvers, Lea Anne Spradlen and Roger Rhodes |
| Actavis Laboratories UT, Inc., Beverly Sackler, Allergan Sales, LLC, Richard S. Sackler, AMNEAL Pharmaceuticals, LLC, Actavis Kadian LLC, Mallinckrodt LLC, Par Pharmaceutical, Inc., Actavis Totowa LLC, Actavis Elizabeth, LLC, Endo Health Solutions, Inc., Teva Pharmaceutical Industries, Ltd., Allergan PLC, Impax Laboratories, LLC, Teva Pharmaceuticals USA, Inc., Actavis South Atlantic LLC, Theresa Sackler, Warner Chilcott Company, LLC, Endo Pharmaceuticals, Inc., David A. Sackler, AMNEAL Pharmaceuticals of New York, LLC, Actavis, LLC, Allergan Finance LLC, Actavis Pharma, Inc., Cephalon, Inc., Par Pharmaceutical Companies, Inc., Mortimer D.A. Sackler, Actavis Mid Atlantic, LLC, Actavis Laboratories FL, Inc., Johnson & Johnson, Watson Laboratories, Inc., Ilene Sackler Lefcourt, Janssen Pharmaceuticals, Inc., Rhodes Technologies, Inc., KVK-Tech, Inc., Kathe A. Sackler, Specgx LLC, Jonathan D. Sackler, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., AMNEAL Pharmaceuticals, Inc., Mallinckrodt Plc,, Allergan USA, Inc. and Rhodes Pharmaceuticals L.P. |
| 3:2019cv00885 |
| October 5, 2019 |
| US District Court for the Middle District of Tennessee |
| Aleta A Trauger |
| Anti-Trust |
| 28 U.S.C. § 1331 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 2, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 17
ORDER: This case is pending transfer to an MDL in the Northern District of Ohio, and the deadline for the filing of responsive pleadings has been extended pending a decision on the transfer. It is therefore ORDERED that the initial case management conference scheduled for December 9, 2019 is CONTINUED, to be reset, if appropriate, by later order of the court. Signed by District Judge Aleta A. Trauger on 12/2/2019. (am)
|
|
Filing 16
ORDER granting #15 Motion for Andrew J. O'Connor and Brien T. O'Connor to Appear Pro Hac Vice. Signed by Kirk L. Davies on 12/2/19. (DOCKET TEXT SUMMARY ONLY-ATTORNEYS MUST OPEN THE PDF AND READ THE ORDER.)(Davies, Kirk)
|
| Filing 15 MOTION for attorney Andrew J. O'Connor; Brien T. O'Connor to Appear Pro Hac Vice (paid $200 PHV fee; receipt number 0650-3040548) by Mallinckrodt LLC, Specgx LLC. (Attachments: #1 Attachment - Declaration of Andrew J. O'Connor, #2 Attachment - Declaration of Brien T. O'Connor, #3 Attachment - Proposed Order)(Zeigler, Jessalyn) |
|
Filing 14
ORDER granting #13 Motion for Extension of Time for Defendant Noramco, Inc. to Answer #1 Complaint. Extensions as requested. Signed by District Judge Aleta A. Trauger on 11/14/2019. (DOCKET TEXT SUMMARY ONLY-ATTORNEYS MUST OPEN THE PDF AND READ THE ORDER.)(hb)
|
| Filing 13 Joint MOTION for Extension of Time to File Answer on behalf of Noramco, Inc. by Roger Rhodes, Anthony Silvers, Lea Anne Spradlen. (Jessee, Thomas) |
|
Filing 12
ORDER: Motion for Extension of Time to Answer the #1 Complaint #11 GRANTED for extensions as requested. Signed by District Judge Aleta A. Trauger on 11/8/19. (dt)
|
| TN State Bar status verified as active for Jessalyn H. Zeigler and Sarah Byer Miller. MA State Bar status verified as active for Brien T. O'Connor and Andrew J. O'Connor. (dt) |
| NOTICE TO COUNSEL Andrew J. O'Connor and Brien T. O'Connor: WITHIN 21 DAYS, counsel shall file a Motion to Appear Pro Hac Vice, a Certificate of Good Standing signed by the Clerk of a United States District Court or a U. S. appellate court where admitted, and pay a fee of $100.00 (LR 83.01(b)). PHV due by 11/29/2019. (dt) |
| Filing 11 MOTION for Extension of Time to File Answer Unopposed Motion for Extension of Time to Respond to Plaintiffs' Complaint by Mallinckrodt LLC, Specgx LLC. (Zeigler, Jessalyn) |
|
Filing 10
ORDER: CORRECTED MOTION for Extension of Time to File Answer #8 is GRANTED for extensions as requested. Signed by District Judge Aleta A. Trauger on 11/4/19. (dt)
|
|
Filing 9
ORDER denying as moot #7 Motion for Extension of Time to Answer to Complaint. Signed by District Judge Aleta A. Trauger on 11/4/19. (dt)
|
| Filing 8 MOTION for Extension of Time to File Answer Unopposed (Corrected) by Allergan Finance LLC, Allergan PLC, Allergan Sales, LLC, Allergan USA, Inc.. (Vlahos, Chris) |
| Filing 7 MOTION for Extension of Time to File Answer Unopposed by Allergan Finance LLC, Allergan PLC, Allergan Sales, LLC, Allergan USA, Inc.. (Vlahos, Chris) |
| Filing 6 Summons issued as to Allergan Finance LLC and Janssen Pharmaceutica, Inc.. (dt) |
| Filing 5 NOTICE of Initial Case Management Conference set for 12/9/2019 at 1:30 PM in Chambers 825 before District Judge Aleta A. Trauger. (dt) |
| Filing 4 Summons issued as to AMNEAL Pharmaceuticals of New York, LLC, AMNEAL Pharmaceuticals, Inc., AMNEAL Pharmaceuticals, LLC, Actavis Elizabeth, LLC, Actavis Kadian LLC, Actavis Laboratories FL, Inc., Actavis Laboratories UT, Inc., Actavis Mid Atlantic, LLC, Actavis Pharma, Inc., Actavis South Atlantic LLC, Actavis Totowa LLC, Actavis, LLC, Allergan PLC, Allergan Sales, LLC, Allergan USA, Inc., Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Impax Laboratories, LLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, KVK-Tech, Inc., Ilene Sackler Lefcourt, Mallinckrodt LLC, Mallinckrodt Plc,, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc., Beverly Sackler, David A. Sackler, Jonathan D. Sackler, Kathe A. Sackler, Mortimer D.A. Sackler, Richard S. Sackler, Theresa Sackler, Specgx LLC, Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Warner Chilcott Company, LLC, Watson Laboratories, Inc., Rhodes Pharmaceuticals L.P. (Service copies returned to counsel by mail.) (dt) |
| Filing 3 NOTICE of Business Entity Disclosure Statement filing requirement. (dt) |
| Filing 2 NOTICE/INFORMATION regarding Consent of the Parties to the Magistrate Judge. (dt) |
| NOTICE TO COUNSEL Gordon Ball and Thomas C. Jessee: WITHIN 21 DAYS, counsel shall be admitted to practice. The application for admission is available on the website at #http://www.tnmd.uscourts.gov/forms/admission-practice-application (LR 83.01(a)). Admission due by 10/29/2019. (dt) |
| TN State Bar status verified as active for Gordon Ball and Thomas C. Jessee. (dt) |
| Filing 1 COMPLAINT against AMNEAL Pharmaceuticals of New York, LLC, AMNEAL Pharmaceuticals, Inc., AMNEAL Pharmaceuticals, LLC, Actavis Elizabeth, LLC, Actavis Kadian LLC, Actavis Laboratories FL, Inc., Actavis Laboratories UT, Inc., Actavis Mid Atlantic, LLC, Actavis Pharma, Inc., Actavis South Atlantic LLC, Actavis Totowa LLC, Actavis, LLC, Allergan Finance LLC, Allergan PLC, Allergan Sales, LLC, Allergan USA, Inc., Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Impax Laboratories, LLC, Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, KVK-Tech, Inc., Ilene Sackler Lefcourt, Mallinckrodt LLC, Mallinckrodt Plc,, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc., Rhodes Technologies, Inc., Beverly Sackler, David A. Sackler, Jonathan D. Sackler, Kathe A. Sackler, Mortimer D.A. Sackler, Richard S. Sackler, Theresa Sackler, Specgx LLC, Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Warner Chilcott Company, LLC and Watson Laboratories, Inc. (Filing fee $400, Receipt number 0650-3007012), filed by Lea Anne Spradlen, Roger Rhodes, Anthony Silvers. (Attachments: #1 Attachment - Civil Cover Sheet)(dt) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Tennessee Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
